Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Stem Cells for Optic Neuropathies
NCT02638714Phase 2Unknown
- Sponsor
- Stem Cells Arabia
- Start
- Apr 2013
- Primary completion
- Sep 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived CD34+ CD133+ CD271+ stem cells in optic nerve atrophy (OA), sponsored by Stem Cells Arabia. Status: unknown.
02
Drugs
autologous bone marrow-derived CD34+ CD133+ CD271+ stem cells
03
Conditions
optic nerve atrophy (OA)
Beyond the preview
Go deeper on NCT02638714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638714.